Evidence map›Paper›PMID 15507640›Full record

ArticleJournal of virology2004

A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism.

Cary A Rue, Michael A Jarvis, Amber J Knoche, Heather L Meyers, Victor R DeFilippis, Scott G Hansen, Markus Wagner, Klaus Früh, David G Anders, Scott W Wong and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Herpesvirus BACs: past, present, and future.Journal of biomedicine & biotechnology · 2011
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Efficient replication of rhesus cytomegalovirus variants in multiple rhesus and human cell types.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  19. Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus.Proceedings of the National Academy of Sciences of the United States of America · 2008
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Cary A RueDepartment of Molecular Microbiology and Immunology, 3181 SW Sam Jackson Road, Oregon Health Sciences University, Portland, OR 97239, USA.
Michael A Jarvis
Amber J Knoche
Heather L Meyers
Victor R DeFilippis
Scott G Hansen
Markus Wagner
Klaus Früh
David G Anders
Scott W Wong
Peter A Barry
Jay A Nelson
Oregon Health & Science University · USHarvard University · USUniversity of California, Davis · USWadsworth Center · US

Funding

YR 50 PROJ- ROBERTS PRIMATE ISLETP51RR000163 · NCRR · OREGON REGIONAL PRIMATE RESEARCH CENTER · PI FRUH, KLAUS J · 1985 to 2011
$140.8M
MOLECULAR ASPECTS OF CYTOMEGALOVIRUS LATENCYR01AI021640 · NIAID · UNIVERSITY OF GUELPH · PI Meaghan H Hancock · 1985 to 2026
$8.1M
Molecular Aspects of Cytomegalovirus LatencyR37AI021640 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HANCOCK, MEAGHAN H · 2018 to 2024
$4.0M
REPRODUCTIVE STEROIDS AND EXPERIMENTAL STROKEK01RR000163 · NCRR · OREGON HEALTH AND SCIENCE UNIVERSITY · PI MURPHY, STEPHANIE J · 2000 to 2004
$479k
A MOLECULAR BASIS FOR THE RHESUS CYTOMEGALOVIRUS MODELR21RR015094 · NCRR · WADSWORTH CENTER · PI ANDERS, DAVID G. · 2001 to 2002
$250k
Growth of rheusus cytomegalovirus in macrophagesF32AI057218 · NIAID · OREGON HEALTH AND SCIENCE UNIVERSITY · PI HANSEN, SCOTT G · 2003 to 2004
$95k
NCRR NIH HHS K01 RR000163NCRR NIH HHS P51 RR000163NCRR NIH HHS R21 RR015094NCRR NIH HHS RR 00163NCRR NIH HHS RR 15094NIAID NIH HHS 5F32 AI 057218-02NIAID NIH HHS AI 21640NIAID NIH HHS F32 AI057218NIAID NIH HHS R01 AI021640NIAID NIH HHS R37 AI021640
6 · The paper itself

Abstract

Cyclooxygenase-2 (COX-2) is a cellular enzyme in the eicosanoid synthetic pathway that mediates the synthesis of prostaglandins from arachidonic acid. The eicosanoids function as critical regulators of a number of cellular processes, including the acute and chronic inflammatory response, hemostasis, and the innate immune response. Human cytomegalovirus (HCMV), which does not encode a viral COX-2 isoform, has been shown to induce cellular COX-2 expression. Importantly, although the precise role of COX-2 in CMV replication is unknown, COX-2 induction was shown to be critical for normal HCMV replication. In an earlier study, we identified an open reading frame (Rh10) within the rhesus cytomegalovirus (RhCMV) genome that encoded a putative protein (designated vCOX-2) with high homology to cellular COX-2. In the current study, we show that vCOX-2 is expressed with early-gene kinetics during RhCMV infection, resulting in production of a 70-kDa protein. Consistent with the expression of a viral COX-2 isoform, cellular COX-2 expression was not induced during RhCMV infection. Finally, analysis of growth of recombinant RhCMV with vCOX-2 deleted identified vCOX-2 as a critical determinant for replication in endothelial cells.

Indexed as

Amino Acid SequenceAnimalsCyclooxygenase 2CytomegalovirusEndothelial CellsIsoenzymesMacaca mulattaMolecular Sequence DataProstaglandin-Endoperoxide SynthasesTropismViral ProteinsVirus ReplicationCyclooxygenase 2IsoenzymesProstaglandin-Endoperoxide SynthasesViral Proteins

Identifiers

PMID15507640
PMCPMC525102
OpenAlexW2164651246

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.